Ozempic maker Novo Nordisk currently charges almost €925 for a month's supply in the US

Novo Nordisk's diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways

The drugs are on track to become some of the best-selling of all-time as pop culture, social media, and third-party marketers  cash in on the hype

Seizures of fake medication claiming to contain semaglutide, found in Ozempic and Wegovy, are increasing in Ireland

With the pandemic boom for makers of vaccines and testing kits unravelling, investors are turning their focus to sectors such as weight-loss drugs

German dialysis provider Fresenius Medical Care's shares plunged as much as 24% in Frankfurt trade on news of the study's results

Doctors are hearing anecdotal reports of reductions in drinking and smoking while taking Ozempic, but experts say that more research is needed, says Donna Lu

'Focus should be on the underlying pathophysiology of obesity and not on body size'

Health Products Regulatory Authority warns of shortage as the #Ozempic hashtag hits over a billion views on Tiktok